In a pilot trial of NAD+ intravenous infusion in healthy adults, subjects receiving 750 mg of NAD+ over 6 hours reported no negative symptoms, and there were no vital sign abnormalities or serious laboratory derangements compared to placebo
H., Petrovic, A., & Seiwerth, S
In this work, histological analysis has confirmed that Remo has the potential to hinder the deleterious effects of TAA
While alternative administration routes, such as intravenous, intramuscular, nasal, percutaneous, and transdermal delivery, have shown promise in certain conditions, these methods can be invasive and uncomfortable for patients
Squellerio and colleagues compared LC-MS/MS with HPLC using electrochemical detection for glutathione measurement and reported improved selectivity and precision for the LC-MS/MS approach in that study setting [13]